FGFR4 and hepatocellular carcinoma: Due to broad ligand binding spectrum of FGFR4, it is reportedly involved in multiple tumor types including HCC, breast cancer, colorectal cancer, rhabdomyosarcoma, and lung cancer [29,30,31,32,33].